Monopegylated Human Growth Hormone

Patent No. EP2305804 (titled "Monopegylated Human Growth Hormone") was filed by Bolder Biotechnology on Jan 14, 2000. The application was issued on May 6, 2015.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ASCENDIS PHARMAFeb 2, 2016BUCHEL

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2305804

BOLDER BIOTECHNOLOGY
Application Number
EP10012486A
Filing Date
Jan 14, 2000
Status
Revoked
Feb 2, 2018
Publication Date
May 6, 2015